These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

866 related items for PubMed ID: 23030331

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
    Timurkaynak F, Can F, Azap OK, Demirbilek M, Arslan H, Karaman SO.
    Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria.
    Li J, Nation RL, Milne RW, Turnidge JD, Coulthard K.
    Int J Antimicrob Agents; 2005 Jan; 25(1):11-25. PubMed ID: 15620821
    [Abstract] [Full Text] [Related]

  • 6. Efficacy of high-dose nebulized colistin in ventilator-associated pneumonia caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii.
    Lu Q, Luo R, Bodin L, Yang J, Zahr N, Aubry A, Golmard JL, Rouby JJ, Nebulized Antibiotics Study Group.
    Anesthesiology; 2012 Dec; 117(6):1335-47. PubMed ID: 23132092
    [Abstract] [Full Text] [Related]

  • 7. Pandrug-resistant Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumannii infections: characteristics and outcome in a series of 28 patients.
    Falagas ME, Rafailidis PI, Matthaiou DK, Virtzili S, Nikita D, Michalopoulos A.
    Int J Antimicrob Agents; 2008 Nov; 32(5):450-4. PubMed ID: 18768302
    [Abstract] [Full Text] [Related]

  • 8. Colistin as a salvage therapy for nosocomial infections caused by multidrug-resistant bacteria in the ICU.
    Kallel H, Bahloul M, Hergafi L, Akrout M, Ketata W, Chelly H, Hamida CB, Rekik N, Hammami A, Bouaziz M.
    Int J Antimicrob Agents; 2006 Oct; 28(4):366-9. PubMed ID: 16971093
    [Abstract] [Full Text] [Related]

  • 9. An update on the arsenal for multidrug-resistant Acinetobacter infections: polymyxin antibiotics.
    Kassamali Z, Jain R, Danziger LH.
    Int J Infect Dis; 2015 Jan; 30():125-32. PubMed ID: 25461655
    [Abstract] [Full Text] [Related]

  • 10. Multidrug-resistant Gram-negative bacteria: how to treat and for how long.
    Giamarellou H.
    Int J Antimicrob Agents; 2010 Dec; 36 Suppl 2():S50-4. PubMed ID: 21129924
    [Abstract] [Full Text] [Related]

  • 11. Treatment of multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii pneumonia.
    Falagas ME, Kasiakou SK, Michalopoulos A.
    J Cyst Fibros; 2005 May; 4(2):149-50. PubMed ID: 15886070
    [No Abstract] [Full Text] [Related]

  • 12. Colistin and polymyxin B in critical care.
    Michalopoulos A, Falagas ME.
    Crit Care Clin; 2008 Apr; 24(2):377-91, x. PubMed ID: 18361952
    [Abstract] [Full Text] [Related]

  • 13. Pharmacokinetics and pharmacodynamics of 'old' polymyxins: what is new?
    Bergen PJ, Landersdorfer CB, Zhang J, Zhao M, Lee HJ, Nation RL, Li J.
    Diagn Microbiol Infect Dis; 2012 Nov; 74(3):213-23. PubMed ID: 22959816
    [Abstract] [Full Text] [Related]

  • 14. Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections.
    Li J, Nation RL, Turnidge JD, Milne RW, Coulthard K, Rayner CR, Paterson DL.
    Lancet Infect Dis; 2006 Sep; 6(9):589-601. PubMed ID: 16931410
    [Abstract] [Full Text] [Related]

  • 15. Emergence of concurrent infections with colistin-resistant ESBL-positive Klebsiella pneumoniae and OXA-23-producing Acinetobacter baumannii sensitive to colistin only in a Romanian cardiac intensive care unit.
    Timofte D, Dan M, Maciuca IE, Ciucu L, Dabija ER, Guguianu E, Panzaru CV.
    Eur J Clin Microbiol Infect Dis; 2015 Oct; 34(10):2069-74. PubMed ID: 26239064
    [Abstract] [Full Text] [Related]

  • 16. Antibiograms of multidrug-resistant clinical Acinetobacter baumannii: promising therapeutic options for treatment of infection with colistin-resistant strains.
    Li J, Nation RL, Owen RJ, Wong S, Spelman D, Franklin C.
    Clin Infect Dis; 2007 Sep 01; 45(5):594-8. PubMed ID: 17682994
    [Abstract] [Full Text] [Related]

  • 17. Nebulized colistin in the treatment of pneumonia due to multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa.
    Kwa AL, Loh C, Low JG, Kurup A, Tam VH.
    Clin Infect Dis; 2005 Sep 01; 41(5):754-7. PubMed ID: 16080101
    [Abstract] [Full Text] [Related]

  • 18. Old agent, new experience: colistin use in the paediatric Intensive Care Unit--a multicentre study.
    Paksu MS, Paksu S, Karadag A, Sensoy G, Asilioglu N, Yildizdas D, Akyildiz BN, Kendirli T, Demirkol D, Akgun M, Alp E, Ciftci E, Guney AK, Murat N.
    Int J Antimicrob Agents; 2012 Aug 01; 40(2):140-4. PubMed ID: 22727770
    [Abstract] [Full Text] [Related]

  • 19. Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections.
    Falagas ME, Kasiakou SK.
    Clin Infect Dis; 2005 May 01; 40(9):1333-41. PubMed ID: 15825037
    [Abstract] [Full Text] [Related]

  • 20. Inhaled colistin monotherapy for respiratory tract infections in adults without cystic fibrosis: a systematic review and meta-analysis.
    Vardakas KZ, Voulgaris GL, Samonis G, Falagas ME.
    Int J Antimicrob Agents; 2018 Jan 01; 51(1):1-9. PubMed ID: 28669836
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 44.